WO2005047512A2 - Plasmid system for multigene expression - Google Patents
Plasmid system for multigene expression Download PDFInfo
- Publication number
- WO2005047512A2 WO2005047512A2 PCT/US2004/037721 US2004037721W WO2005047512A2 WO 2005047512 A2 WO2005047512 A2 WO 2005047512A2 US 2004037721 W US2004037721 W US 2004037721W WO 2005047512 A2 WO2005047512 A2 WO 2005047512A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- eco
- plasmid
- seq
- expression cassette
- plasmid system
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04810783A EP1694850B1 (en) | 2003-11-12 | 2004-11-10 | Plasmid system for multigene expression |
CA002545755A CA2545755A1 (en) | 2003-11-12 | 2004-11-10 | Plasmid system for multigene expression |
AT04810783T ATE514783T1 (de) | 2003-11-12 | 2004-11-10 | Plasmidsystem zur expression mehrerer gene |
JP2006539876A JP2007510434A (ja) | 2003-11-12 | 2004-11-10 | 多重遺伝子発現のためのプラスミドシステム |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51923003P | 2003-11-12 | 2003-11-12 | |
US60/519,230 | 2003-11-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005047512A2 true WO2005047512A2 (en) | 2005-05-26 |
WO2005047512A3 WO2005047512A3 (en) | 2005-06-23 |
Family
ID=34590376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/037721 WO2005047512A2 (en) | 2003-11-12 | 2004-11-10 | Plasmid system for multigene expression |
Country Status (8)
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007021353A2 (en) * | 2005-06-10 | 2007-02-22 | Genentech, Inc. | Improving antibody expression using vectors containing insulator elements |
JP2009508533A (ja) * | 2005-09-22 | 2009-03-05 | イントレキソン コーポレーション | Dnaモジュラークローニングベクタープラスミドおよびそれらの使用方法 |
WO2010018444A2 (en) * | 2008-08-12 | 2010-02-18 | Avesthagen Limited | An expression vector and a method thereof |
WO2010049777A1 (en) * | 2008-10-28 | 2010-05-06 | Avesthagen Limited | An expression vector and processes thereof |
JP2010523082A (ja) * | 2007-03-30 | 2010-07-15 | アボット・ラボラトリーズ | 宿主細胞中の組換えタンパク質の発現を増進するための組換え発現ベクター要素(rEVE) |
WO2011015918A2 (en) * | 2009-08-03 | 2011-02-10 | Avesthagen Limited | Vectors and compounds for expression of recombinant cetuximab |
WO2011015917A2 (en) * | 2009-08-03 | 2011-02-10 | Avesthagen Limited | Vectors and compounds for expression of recombinant tnk-tpa (tenecteplase) |
WO2011015916A2 (en) * | 2009-08-03 | 2011-02-10 | Avesthagen Limited | Vectors and compounds for expression of recombinant infliximab |
WO2011015924A2 (en) * | 2009-08-03 | 2011-02-10 | Avesthagen Limited | Vectors and compounds for expression of recombinant trastuzumab |
JP2011527567A (ja) * | 2008-07-10 | 2011-11-04 | アプロゲン インコーポレーテッド | 動物細胞用組み換え発現ベクター |
EP2405270A1 (en) | 2006-06-30 | 2012-01-11 | Schering Corporation | IGFBP2-Biomarker |
EP2468768A2 (en) | 2005-07-21 | 2012-06-27 | Abbott Laboratories | Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis |
CN102703498A (zh) * | 2012-06-04 | 2012-10-03 | 河北农业大学 | 多基因植物表达载体及其构建方法和应用 |
EP2694655A1 (en) * | 2011-04-08 | 2014-02-12 | Merck Sharp & Dohme Corp. | pAVEC |
US8945876B2 (en) | 2011-11-23 | 2015-02-03 | University Of Hawaii | Auto-processing domains for polypeptide expression |
CN116284442A (zh) * | 2023-02-08 | 2023-06-23 | 中国农业科学院生物技术研究所 | 一种控制叶片颜色的融合蛋白及其在植物转录因子与dna互作研究上的应用 |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ571508A (en) * | 2002-05-24 | 2010-05-28 | Schering Corp | Neutralizing human anti-IGFR antibody |
US7785871B2 (en) * | 2002-10-09 | 2010-08-31 | Intrexon Corporation | DNA cloning vector plasmids and methods for their use |
TW200526684A (en) * | 2003-11-21 | 2005-08-16 | Schering Corp | Anti-IGFR1 antibody therapeutic combinations |
EP1751298A4 (en) | 2004-05-18 | 2009-11-11 | Intrexon Corp | METHOD FOR DYNAMIC VECTOR ASSEMBLY OF DNA CLONING VECTOR PLASMIDES |
DE602005027407D1 (de) * | 2004-11-18 | 2011-05-19 | Univ Hiroshima Nat Univ Corp | Verfahren und Kit zur Proteinexpression und Regelung der Expression wiederholter Sequenzen, die durch Genamplifikation und -transformierung gebildet werden |
US7811562B2 (en) * | 2004-12-03 | 2010-10-12 | Schering Corporation | Biomarkers for pre-selection of patients for anti-IGF1R therapy |
MX2007012896A (es) * | 2005-04-15 | 2007-12-10 | Schering Corp | Metodos y composiciones para tratamiento o prevencion de cancer. |
US8153598B2 (en) * | 2005-10-19 | 2012-04-10 | Intrexon Corporation | PKD ligands and polynucleotides encoding PKD ligands |
US8137933B2 (en) | 2008-11-12 | 2012-03-20 | Schering Corporation | Mammalian expression vector pUHAB |
CN102369285B (zh) * | 2008-11-12 | 2014-06-18 | 默沙东公司 | 用于增强的抗-IGF1R表达的βGl-IgG内含子 |
CN103038343A (zh) | 2010-03-23 | 2013-04-10 | 英特瑞克斯顿股份有限公司 | 条件表达治疗蛋白的载体,包含所述载体的宿主细胞,及其应用 |
KR102007055B1 (ko) | 2011-09-22 | 2019-08-02 | 암젠 인크 | Cd27l 항원 결합 단백질 |
CN102559750B (zh) * | 2011-11-25 | 2014-03-12 | 佛山安普泽生物医药有限公司 | 一种抗体的高效表达载体及其制备方法 |
AR091069A1 (es) | 2012-05-18 | 2014-12-30 | Amgen Inc | Proteinas de union a antigeno dirigidas contra el receptor st2 |
UY35148A (es) | 2012-11-21 | 2014-05-30 | Amgen Inc | Immunoglobulinas heterodiméricas |
US9546203B2 (en) | 2013-03-14 | 2017-01-17 | Amgen Inc. | Aglycosylated Fc-containing polypeptides with cysteine substitutions |
WO2014144817A2 (en) | 2013-03-15 | 2014-09-18 | Amgen Inc. | Inhibitory polypeptides specific to wnt inhibitors |
PL3456743T3 (pl) | 2013-05-30 | 2022-03-07 | Kiniksa Pharmaceuticals, Ltd. | Białka wiążące antygen receptora onkostatyny m |
JP6668241B2 (ja) | 2013-09-05 | 2020-03-18 | アムジエン・インコーポレーテツド | 予測可能で、一貫性のある、且つ再現可能な糖型特性を示すFc含有分子 |
UA126270C2 (uk) | 2015-04-10 | 2022-09-14 | Емджен Інк. | Мутеїни інтерлейкіну-2 для росту регуляторних t-клітин |
CA2980189A1 (en) | 2015-04-24 | 2016-10-27 | Genentech, Inc. | Multispecific antigen-binding proteins |
EP3699269A1 (en) | 2015-09-22 | 2020-08-26 | F. Hoffmann-La Roche AG | Expression of fc-containing proteins |
KR20180069839A (ko) | 2015-10-08 | 2018-06-25 | 자임워크스 인코포레이티드 | 카파 및 람다 경사슬을 포함하는 항원-결합 폴리펩티드 구조체 및 이의 용도 |
WO2017079165A1 (en) | 2015-11-02 | 2017-05-11 | Genentech, Inc. | Methods of making fucosylated and afucosylated forms of a protein |
KR20180133198A (ko) | 2016-05-04 | 2018-12-13 | 암젠 인크 | T-조절 세포의 증식을 위한 인터류킨-2 뮤테인 |
JP7245793B2 (ja) | 2017-06-30 | 2023-03-24 | ザイムワークス ビーシー インコーポレイテッド | 安定化したキメラFab |
NZ767146A (en) | 2018-02-27 | 2022-07-01 | Roger Thomas MASCULL and Elizabeth Jocelyn MASCULL as Trustees of the RT and EJ Family Trust | A seating support |
US20220267802A1 (en) * | 2019-07-15 | 2022-08-25 | President And Fellows Of Harvard College | Methods and compositions for gene delivery |
MX2022001866A (es) | 2019-08-13 | 2022-03-11 | Amgen Inc | Muteinas de interleucina-2 para la expansion de celulas t reguladoras. |
CN112941028A (zh) * | 2019-12-09 | 2021-06-11 | 上海细胞治疗集团有限公司 | 纳米抗体基因修饰的间充质干细胞及其制备方法与应用 |
CA3162705A1 (en) | 2019-12-17 | 2021-06-24 | Amgen Inc. | Dual interleukin-2 /tnf receptor agonist for use in therapy |
Family Cites Families (112)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4543439A (en) | 1982-12-13 | 1985-09-24 | Massachusetts Institute Of Technology | Production and use of monoclonal antibodies to phosphotyrosine-containing proteins |
US5534617A (en) | 1988-10-28 | 1996-07-09 | Genentech, Inc. | Human growth hormone variants having greater affinity for human growth hormone receptor at site 1 |
US5977307A (en) | 1989-09-07 | 1999-11-02 | Alkermes, Inc. | Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
WO1991004014A1 (en) | 1989-09-21 | 1991-04-04 | Synergen, Inc. | Method for transporting compositions across the blood brain barrier |
EP0517768A1 (en) | 1990-02-28 | 1992-12-16 | Schering Corporation | Mammalian expression vectors |
AU654811B2 (en) | 1990-03-20 | 1994-11-24 | Trustees Of Columbia University In The City Of New York, The | Chimeric antibodies with receptor binding ligands in place of their constant region |
US6300129B1 (en) | 1990-08-29 | 2001-10-09 | Genpharm International | Transgenic non-human animals for producing heterologous antibodies |
JPH04166089A (ja) * | 1990-10-30 | 1992-06-11 | Eiken Chem Co Ltd | 免疫グロブリン遺伝子発現用プラスミドベクター、及びそれを用いてv領域の遺伝子を組換える方法 |
US5198340A (en) | 1991-01-17 | 1993-03-30 | Genentech, Inc. | Assay for free igf-i, igf-ii, and gh levels in body fluids |
US5262308A (en) | 1992-01-28 | 1993-11-16 | Thomas Jefferson University | Cell lines which constitutively express IGF-1 and IGF-1 R |
ATE191853T1 (de) | 1992-07-27 | 2000-05-15 | Us Health | Zielgerichte liposome zur blut-hirne schranke |
JPH08508409A (ja) | 1993-04-06 | 1996-09-10 | シーダーズ − サイナイ メディカル センター | 変異インスリン様増殖因子▲i▼受容体サブユニットおよびそれらの使用方法 |
US20020022023A1 (en) | 1999-01-15 | 2002-02-21 | Axel Ullrich | Treatment of diabetes mellitus and insulin receptor signal transduction |
CN1241944C (zh) * | 1995-09-11 | 2006-02-15 | 协和发酵工业株式会社 | 抗人白介素-5受体α链的抗体 |
US6084085A (en) | 1995-11-14 | 2000-07-04 | Thomas Jefferson University | Inducing resistance to tumor growth with soluble IGF-1 receptor |
US6346390B1 (en) | 1996-03-08 | 2002-02-12 | Receptron, Inc. | Receptor derived peptides involved in modulation of response to ligand binding |
US5958872A (en) | 1996-04-01 | 1999-09-28 | Apoptosis Technology, Inc. | Active survival domains of IGF-IR and methods of use |
US20020187925A1 (en) | 1996-05-22 | 2002-12-12 | Kingston David J. | Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof |
AUPN999096A0 (en) | 1996-05-22 | 1996-06-13 | Northstar Biologicals Pty Ltd | Peptides, antibodies, vaccines & uses thereof |
US20020155095A1 (en) | 1996-10-18 | 2002-10-24 | Tattanahalli L. Nagabhushan | Methods and compositions for delivery and expression of interferon-a nucleic acids |
AU4808097A (en) | 1996-10-18 | 1998-05-15 | Canji, Inc. | Methods and compositions for delivery and expression of interferon-alpha nucleic acids |
WO1998022092A1 (en) | 1996-11-22 | 1998-05-28 | The Regents Of The University Of California | Transport of liposomes across the blood-brain barrier |
US6399789B1 (en) * | 1996-12-18 | 2002-06-04 | Kosan Biosciences, Inc. | Multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides |
US6294330B1 (en) | 1997-01-31 | 2001-09-25 | Odyssey Pharmaceuticals Inc. | Protein fragment complementation assays for the detection of biological or drug interactions |
TW562807B (en) * | 1997-04-01 | 2003-11-21 | Chugai Pharmaceutical Co Ltd | Novel secretory membrane protein |
US6121416A (en) | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
JPH1132779A (ja) * | 1997-07-24 | 1999-02-09 | Fujita Gakuen | 蛋白質の遺伝子クローニング法 |
IL136113A0 (en) | 1997-11-14 | 2001-05-20 | Euro Celtique Sa | Modified antibodies with enhanced ability to elicit an anti-idiotype response |
WO1999028347A1 (en) | 1997-11-27 | 1999-06-10 | Commonwealth Scientific And Industrial Research Organisation | Method of designing agonists and antagonists to igf receptor |
CA2322200A1 (en) | 1998-02-24 | 1999-08-26 | Receptron, Inc. | Receptor derived peptides as modulators of receptor activity |
ZA200007412B (en) | 1998-05-15 | 2002-03-12 | Imclone Systems Inc | Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases. |
CA2332331A1 (en) | 1998-05-15 | 1999-11-25 | Francisco Robert | Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases |
US7173005B2 (en) | 1998-09-02 | 2007-02-06 | Antyra Inc. | Insulin and IGF-1 receptor agonists and antagonists |
US6875741B2 (en) | 1998-09-02 | 2005-04-05 | Renuka Pillutla | Insulin and IGF-1 receptor agonists and antagonists |
US20030236190A1 (en) | 1998-09-02 | 2003-12-25 | Renuka Pillutla | Isulin and IGF-1 receptor agonists and antagonists |
EP1953229A3 (en) | 1998-10-15 | 2008-12-24 | Novartis Vaccines and Diagnostics, Inc. | Metastatic breast and colon cancer regulated genes |
AU3579200A (en) | 1999-02-26 | 2000-09-14 | Saltech I Goteborg Ab | Method and composition for the regulation of hepatic and extrahepatic productionof insulin-like growth factor-1 |
US6316462B1 (en) | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
US6511967B1 (en) * | 1999-04-23 | 2003-01-28 | The General Hospital Corporation | Use of an internalizing transferrin receptor to image transgene expression |
WO2000069454A1 (en) | 1999-05-17 | 2000-11-23 | Board Of Regents, The University Of Texas System | Suppression of endogenous igfbp-2 to inhibit cancer |
WO2001007084A1 (en) | 1999-07-23 | 2001-02-01 | Regents Of The University Of California | Anti-growth factor receptor avidin fusion proteins as universal vectors for drug delivery |
AU1339701A (en) | 1999-10-22 | 2001-05-08 | Lifespan Biosciences, Inc. | Anti-cancer nucleic acid and protein targets |
EP2278021A3 (en) * | 1999-11-01 | 2011-05-18 | Novartis Vaccines and Diagnostics, Inc. | Expression vectors, transfection systems, and method of use thereof |
AU1410801A (en) | 1999-11-17 | 2001-05-30 | Compugen Ltd. | Variants of alternative splicing |
WO2001044464A1 (en) | 1999-12-15 | 2001-06-21 | Mcgill University | Targeting of endosomal growth factor processing as anti-cancer therapy |
AU2001245888A1 (en) | 2000-03-21 | 2001-10-03 | University Of South Florida | Growth factor binding molecules |
EP1265635A1 (en) | 2000-03-22 | 2002-12-18 | Glaxo Group Limited | Pharmaceutical comprising an agent that blocks the cell cycle and an antibody |
TWI310684B (en) | 2000-03-27 | 2009-06-11 | Bristol Myers Squibb Co | Synergistic pharmaceutical kits for treating cancer |
CA2402780A1 (en) | 2000-03-29 | 2001-10-04 | Dgi Biotechnologies, L.L.C. | Insulin and igf-1 receptor agonists and antagonists |
AU5521401A (en) | 2000-03-31 | 2001-10-15 | Hyseq Inc | Method and materials relating to insulin-like growth factor binding protein-likepolypeptides and polynucleotides |
US6372250B1 (en) | 2000-04-25 | 2002-04-16 | The Regents Of The University Of California | Non-invasive gene targeting to the brain |
GB0012233D0 (en) | 2000-05-19 | 2000-07-12 | Devgen Nv | Vector constructs |
US7329745B2 (en) | 2000-06-13 | 2008-02-12 | City Of Hope | Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth |
US20030165502A1 (en) | 2000-06-13 | 2003-09-04 | City Of Hope | Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth |
WO2002004522A2 (en) | 2000-07-10 | 2002-01-17 | Novartis Ag | Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
US20020164333A1 (en) | 2000-07-10 | 2002-11-07 | The Scripps Research Institute | Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
WO2002007783A2 (en) | 2000-07-20 | 2002-01-31 | Regents Of The University Of Minnesota | Radiolabeled immunotoxins |
KR100408844B1 (ko) * | 2000-07-29 | 2003-12-06 | 한국산업기술평가원 | 동물세포 발현벡터 |
US20030162230A1 (en) | 2000-09-27 | 2003-08-28 | Reagan Kevin J. | Method for quantifying phosphokinase activity on proteins |
US8153121B2 (en) | 2000-10-06 | 2012-04-10 | Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center | Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders |
DE10050338A1 (de) | 2000-10-11 | 2002-04-25 | Deutsches Krebsforsch | Auf dem Nachweis von IGF-IRbeta und IRS-1 beruhendes Diagnose- bzw. Klassifizierungsverfahren für Carcinome |
MXPA03003207A (es) | 2000-10-12 | 2004-03-26 | Icos Corp | Materiales y metodos para modular la actividad de union de ligando/enzimatica de proteinas alfa/¦ que contienen un sitio regulador alosterico. |
EP1332368A2 (en) | 2000-11-03 | 2003-08-06 | Board of Regents, The University of Texas System | Methods for detecting the efficacy of anticancer treatments |
JP2004517078A (ja) | 2000-12-01 | 2004-06-10 | シェーリング コーポレイション | 哺乳動物遺伝子および関連試薬の使用 |
DE60140074D1 (de) | 2000-12-14 | 2009-11-12 | Burnham Inst | Non-apoptotische formen des zelltods und verfahren zur modulation |
HUP0302525A2 (hu) | 2001-01-05 | 2003-10-28 | Abgenix, Inc. | Az inzulinszerű növekedési faktor I receptor elleni ellenanyagok |
ATE437233T1 (de) | 2001-01-26 | 2009-08-15 | Selexis Sa | Matrix-anheftungsregionen und verfahren zu deren verwendung |
EP1401476A4 (en) | 2001-03-14 | 2006-03-08 | Genentech Inc | IGF ANTAGONIST PEPTIDES |
FR2824076B1 (fr) | 2001-04-27 | 2003-06-13 | Centre Nat Rech Scient | Methode de detection de composes activateurs ou inhibiteurs des recepteurs de la famille du recepteur de l'insuline au moyen d'un recepteur chimere isole |
US20040116330A1 (en) | 2001-04-27 | 2004-06-17 | Kenichiro Naito | Preventive/therapeutic method for cancer |
US7498029B2 (en) | 2001-05-01 | 2009-03-03 | The General Hospital Corporation | Photoimmunotherapies for cancer using combination therapies |
TWI238824B (en) | 2001-05-14 | 2005-09-01 | Novartis Ag | 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives |
WO2002102854A2 (en) | 2001-06-20 | 2002-12-27 | Morphosys Ag | Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
JP2005500833A (ja) | 2001-06-25 | 2005-01-13 | ブアズーボ・アンパルトセルスカブ | 腫瘍学薬物の革新 |
US20040253635A1 (en) | 2001-08-06 | 2004-12-16 | Sylvie Luria | Methods of identifying functional analogs of peptide regulators of biological pathways |
AUPR870501A0 (en) | 2001-11-07 | 2001-11-29 | Biotech Research Ventures Pte Limited | Composition containing a flavonoid glycone and method for using same as anti-proliferative |
FR2834990A1 (fr) | 2002-01-18 | 2003-07-25 | Pf Medicament | Nouveaux anticorps anti-igf-ir et leurs applications |
US7553485B2 (en) | 2002-01-18 | 2009-06-30 | Pierre Fabre Medicament | Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof |
US7241444B2 (en) | 2002-01-18 | 2007-07-10 | Pierre Fabre Medicament | Anti-IGF-IR antibodies and uses thereof |
FR2834900B1 (fr) | 2002-01-18 | 2005-07-01 | Pf Medicament | Nouvelles compositions a activite anti-igf-ir et anti-egfr et leurs applications |
FR2834991B1 (fr) | 2002-01-18 | 2004-12-31 | Pf Medicament | Nouveaux anticorps anti-igf-ir et leurs applications |
CA2473039C (fr) | 2002-01-18 | 2014-09-23 | Pierre Fabre Medicament | Nouveaux anticorps anti-igf-ir et leurs applications |
AU2003223661A1 (en) | 2002-04-15 | 2003-11-03 | Rigel Pharmaceuticals, Inc. | Methods of assaying for cell cycle modulators |
US7655397B2 (en) | 2002-04-25 | 2010-02-02 | The United States Of America As Represented By The Department Of Health And Human Services | Selections of genes and methods of using the same for diagnosis and for targeting the therapy of select cancers |
US7485314B2 (en) | 2002-05-06 | 2009-02-03 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Induction of antigen specific immunologic tolerance |
NZ571508A (en) | 2002-05-24 | 2010-05-28 | Schering Corp | Neutralizing human anti-IGFR antibody |
GB0212303D0 (en) | 2002-05-28 | 2002-07-10 | Isis Innovation | Molecular targetting of IGF-1 receptor |
US7538195B2 (en) | 2002-06-14 | 2009-05-26 | Immunogen Inc. | Anti-IGF-I receptor antibody |
US8034904B2 (en) | 2002-06-14 | 2011-10-11 | Immunogen Inc. | Anti-IGF-I receptor antibody |
WO2004007673A2 (en) | 2002-07-12 | 2004-01-22 | The Johns Hopkins University | Neuronal gene expression patterns |
US20040142381A1 (en) | 2002-07-31 | 2004-07-22 | Hubbard Stevan R. | Methods for designing IGF1 receptor modulators for therapeutics |
US20040047835A1 (en) | 2002-09-06 | 2004-03-11 | Cell Therapeutics, Inc. | Combinatorial drug therapy using polymer drug conjugates |
US20030138430A1 (en) | 2002-09-20 | 2003-07-24 | Stimmel Julie Beth | Pharmaceutical comprising an agent that blocks the cell cycle and an antibody |
TW200501960A (en) | 2002-10-02 | 2005-01-16 | Bristol Myers Squibb Co | Synergistic kits and compositions for treating cancer |
US20040102360A1 (en) | 2002-10-30 | 2004-05-27 | Barnett Stanley F. | Combination therapy |
US20060281130A1 (en) | 2002-12-20 | 2006-12-14 | Elisabeth Bock | Metod of modulation of interaction between receptor and ligand |
MXPA05008617A (es) | 2003-02-13 | 2005-11-04 | Pfizer Prod Inc | Usos de anticuerpos anti-receptor del factor de crecimiento semejante a la insulina i. |
BRPI0408317A (pt) | 2003-03-14 | 2006-03-07 | Pharmacia Corp | anticorpos do receptor de igf-i para o tratamento de cáncer |
JP4473257B2 (ja) | 2003-04-02 | 2010-06-02 | エフ.ホフマン−ラ ロシュ アーゲー | インスリン様成長因子i受容体に対する抗体及びその使用 |
US20050043233A1 (en) | 2003-04-29 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis |
EP1622942B1 (en) | 2003-05-01 | 2014-11-19 | ImClone LLC | Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
US7579157B2 (en) | 2003-07-10 | 2009-08-25 | Hoffmann-La Roche Inc. | Antibody selection method against IGF-IR |
MXPA06001634A (es) | 2003-08-13 | 2006-04-28 | Pfizer Prod Inc | Anticuerpos humanos modificados igf-1r. |
DE10348391B3 (de) | 2003-10-17 | 2004-12-23 | Beru Ag | Verfahren zum Glühen einer Glühkerze für einen Dieselmotor |
TW200526684A (en) | 2003-11-21 | 2005-08-16 | Schering Corp | Anti-IGFR1 antibody therapeutic combinations |
EP1796711A2 (en) | 2004-04-22 | 2007-06-20 | Oregon Health and Science University | Herstatin or intron 8-encoded domain thereof for modulating signaling mediated by igf-1 receptor and erbb receptors |
WO2005117980A1 (en) | 2004-06-04 | 2005-12-15 | Pfizer Products Inc. | Method for treating abnormal cell growth |
EP1802341A1 (en) | 2004-07-16 | 2007-07-04 | Pfizer Products Inc. | Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody |
WO2006020258A2 (en) | 2004-07-17 | 2006-02-23 | Imclone Systems Incorporated | Novel tetravalent bispecific antibody |
FR2873699B1 (fr) | 2004-07-29 | 2009-08-21 | Pierre Fabre Medicament Sa | Nouveaux anticorps anti igf ir rt leurs utilisations |
US7612181B2 (en) | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
WO2007093008A1 (en) | 2006-02-17 | 2007-08-23 | Adelaide Research & Innovation Pty Ltd | Antibodies to insulin-like growth factor i receptor |
-
2004
- 2004-11-10 WO PCT/US2004/037721 patent/WO2005047512A2/en active Application Filing
- 2004-11-10 US US10/986,498 patent/US7326567B2/en not_active Expired - Fee Related
- 2004-11-10 CN CNA2004800401656A patent/CN1938428A/zh active Pending
- 2004-11-10 CA CA002545755A patent/CA2545755A1/en not_active Abandoned
- 2004-11-10 JP JP2006539876A patent/JP2007510434A/ja active Pending
- 2004-11-10 AT AT04810783T patent/ATE514783T1/de not_active IP Right Cessation
- 2004-11-10 EP EP04810783A patent/EP1694850B1/en active Active
-
2006
- 2006-05-10 ZA ZA200603731A patent/ZA200603731B/xx unknown
-
2007
- 2007-11-05 JP JP2007287936A patent/JP2008061650A/ja active Pending
- 2007-11-19 US US11/986,041 patent/US8062886B2/en not_active Expired - Fee Related
-
2011
- 2011-10-18 US US13/275,746 patent/US8470593B2/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
None |
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007021353A2 (en) * | 2005-06-10 | 2007-02-22 | Genentech, Inc. | Improving antibody expression using vectors containing insulator elements |
WO2007021353A3 (en) * | 2005-06-10 | 2007-08-30 | Tanox Inc | Improving antibody expression using vectors containing insulator elements |
EP2468768A2 (en) | 2005-07-21 | 2012-06-27 | Abbott Laboratories | Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis |
EP2468881A2 (en) | 2005-07-21 | 2012-06-27 | Abbott Laboratories | Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis |
EP2484774A2 (en) | 2005-07-21 | 2012-08-08 | Abbott Laboratories | Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis |
JP2009508533A (ja) * | 2005-09-22 | 2009-03-05 | イントレキソン コーポレーション | Dnaモジュラークローニングベクタープラスミドおよびそれらの使用方法 |
EP2405270A1 (en) | 2006-06-30 | 2012-01-11 | Schering Corporation | IGFBP2-Biomarker |
US8410259B2 (en) | 2007-03-30 | 2013-04-02 | Abbvie Inc. | Recombinant expression vector elements (REVES) for enhancing expression of recombinant proteins in host cells |
JP2014012014A (ja) * | 2007-03-30 | 2014-01-23 | Abbvie Inc | 宿主細胞中の組換えタンパク質の発現を増進するための組換え発現ベクター要素(rEVE) |
JP2010523082A (ja) * | 2007-03-30 | 2010-07-15 | アボット・ラボラトリーズ | 宿主細胞中の組換えタンパク質の発現を増進するための組換え発現ベクター要素(rEVE) |
JP2011527567A (ja) * | 2008-07-10 | 2011-11-04 | アプロゲン インコーポレーテッド | 動物細胞用組み換え発現ベクター |
WO2010018444A3 (en) * | 2008-08-12 | 2010-05-14 | Avesthagen Limited | An expression vector and a method thereof |
WO2010018444A2 (en) * | 2008-08-12 | 2010-02-18 | Avesthagen Limited | An expression vector and a method thereof |
WO2010049777A1 (en) * | 2008-10-28 | 2010-05-06 | Avesthagen Limited | An expression vector and processes thereof |
WO2011015918A2 (en) * | 2009-08-03 | 2011-02-10 | Avesthagen Limited | Vectors and compounds for expression of recombinant cetuximab |
WO2011015916A2 (en) * | 2009-08-03 | 2011-02-10 | Avesthagen Limited | Vectors and compounds for expression of recombinant infliximab |
WO2011015916A3 (en) * | 2009-08-03 | 2011-04-21 | Avesthagen Limited | Vectors and compounds for expression of recombinant infliximab |
WO2011015918A3 (en) * | 2009-08-03 | 2011-04-21 | Avesthagen Limited | Vectors and compounds for expression of recombinant cetuximab |
WO2011015924A3 (en) * | 2009-08-03 | 2011-04-21 | Avesthagen Limited | Vectors and compounds for expression of recombinant trastuzumab |
WO2011015924A2 (en) * | 2009-08-03 | 2011-02-10 | Avesthagen Limited | Vectors and compounds for expression of recombinant trastuzumab |
WO2011015917A2 (en) * | 2009-08-03 | 2011-02-10 | Avesthagen Limited | Vectors and compounds for expression of recombinant tnk-tpa (tenecteplase) |
WO2011015917A3 (en) * | 2009-08-03 | 2011-04-21 | Avesthagen Limited | Vectors and compounds for expression of recombinant tnk-tpa (tenecteplase) |
EP2694655A1 (en) * | 2011-04-08 | 2014-02-12 | Merck Sharp & Dohme Corp. | pAVEC |
EP2694655A4 (en) * | 2011-04-08 | 2015-01-14 | Merck Sharp & Dohme | pavec |
US9080177B2 (en) | 2011-04-08 | 2015-07-14 | Merck Sharp & Dohme Corp. | pAVEC |
US8945876B2 (en) | 2011-11-23 | 2015-02-03 | University Of Hawaii | Auto-processing domains for polypeptide expression |
CN102703498A (zh) * | 2012-06-04 | 2012-10-03 | 河北农业大学 | 多基因植物表达载体及其构建方法和应用 |
CN116284442A (zh) * | 2023-02-08 | 2023-06-23 | 中国农业科学院生物技术研究所 | 一种控制叶片颜色的融合蛋白及其在植物转录因子与dna互作研究上的应用 |
CN116284442B (zh) * | 2023-02-08 | 2023-10-17 | 中国农业科学院生物技术研究所 | 一种控制叶片颜色的融合蛋白及其在植物转录因子与dna互作研究上的应用 |
Also Published As
Publication number | Publication date |
---|---|
ATE514783T1 (de) | 2011-07-15 |
US20120040402A1 (en) | 2012-02-16 |
JP2008061650A (ja) | 2008-03-21 |
JP2007510434A (ja) | 2007-04-26 |
ZA200603731B (en) | 2010-10-27 |
WO2005047512A3 (en) | 2005-06-23 |
US20050176099A1 (en) | 2005-08-11 |
US8062886B2 (en) | 2011-11-22 |
EP1694850B1 (en) | 2011-06-29 |
US8470593B2 (en) | 2013-06-25 |
US7326567B2 (en) | 2008-02-05 |
CN1938428A (zh) | 2007-03-28 |
US20080311623A1 (en) | 2008-12-18 |
EP1694850A2 (en) | 2006-08-30 |
CA2545755A1 (en) | 2005-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1694850B1 (en) | Plasmid system for multigene expression | |
USRE49347E1 (en) | Mammalian expression vector | |
JP4489424B2 (ja) | 染色体に基くプラットホーム | |
JP2008522589A (ja) | 組換えタンパク質の発現のための方法及び材料 | |
WO2010140387A1 (ja) | 高生産性細胞の樹立のための発現ベクター及び高生産性細胞 | |
CN104884467A (zh) | 在遗传修饰的哺乳动物细胞中生产治疗性蛋白质 | |
US9062326B2 (en) | Expression vector for animal cells | |
RU2656142C1 (ru) | РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pBiPr-ABIgA1FI6-ht ДЛЯ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО ИММУНОГЛОБУЛИНА А ИЗОТИПА IGA1 | |
US9528125B2 (en) | Mammalian expression vector pUHAB | |
CA1324097C (en) | Inducible heat shock and amplification system | |
JP2022529063A (ja) | 安定的な標的組み込み | |
MXPA06005307A (en) | Plasmid system for multigene expression | |
RU2664184C2 (ru) | РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pBiPr-ABIgA1FI6-Intht ДЛЯ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО ИММУНОГЛОБУЛИНА А ИЗОТИПА IgA1 | |
RU2671477C2 (ru) | РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pBiPr-ABIgA2m1F16-ht ДЛЯ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО ИММУНОГЛОБУЛИНА А ИЗОТИПА IGA2m1 | |
JP2003530886A (ja) | 組換え宿主細胞により対象タンパク質の発現を向上させる方法 | |
Dröge | Mammalian Expression Systems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006539876 Country of ref document: JP Ref document number: 200603731 Country of ref document: ZA Ref document number: 2545755 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2006/005307 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004810783 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200480040165.6 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2004810783 Country of ref document: EP |